RUSSO, Simonetta
 Distribuzione geografica
Continente #
EU - Europa 55
NA - Nord America 19
AS - Asia 12
SA - Sud America 4
Totale 90
Nazione #
IT - Italia 23
IE - Irlanda 19
US - Stati Uniti d'America 17
TR - Turchia 8
FR - Francia 6
AR - Argentina 4
CZ - Repubblica Ceca 2
GB - Regno Unito 2
IL - Israele 2
JP - Giappone 2
MX - Messico 2
FI - Finlandia 1
NL - Olanda 1
SE - Svezia 1
Totale 90
Città #
Dublin 19
Parma 15
Buenos Aires 4
Tappahannock 4
Council Bluffs 3
Istanbul 3
Higashifukai 2
London 2
Milan 2
Paris 2
Puebla City 2
Reggio Nell'emilia 2
Roswell 2
Silver Spring 2
Tel Aviv 2
Borås 1
Brighton 1
Edirne 1
Helsinki 1
Izmir 1
Mcallen 1
Nashville 1
Piacenza 1
Shreveport 1
Totale 75
Nome #
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor, file e177fbc7-500b-50b0-e053-d805fe0adaee 25
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism, file e177fbc8-1bab-50b0-e053-d805fe0adaee 24
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey, file e177fbc7-1720-50b0-e053-d805fe0adaee 11
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice, file e177fbc7-4f27-50b0-e053-d805fe0adaee 7
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction, file e177fbc7-4f63-50b0-e053-d805fe0adaee 5
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties, file e177fbc7-9ebc-50b0-e053-d805fe0adaee 5
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism, file e177fbc6-9d97-50b0-e053-d805fe0adaee 3
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors, file e177fbc4-8d3c-50b0-e053-d805fe0adaee 2
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction, file e177fbc4-a2da-50b0-e053-d805fe0adaee 2
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor., file e177fbc4-37d7-50b0-e053-d805fe0adaee 1
Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein–Protein Antagonists, file e177fbc4-3b43-50b0-e053-d805fe0adaee 1
Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor., file e177fbc4-3cbb-50b0-e053-d805fe0adaee 1
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice, file e177fbc7-5252-50b0-e053-d805fe0adaee 1
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction, file e177fbc7-558e-50b0-e053-d805fe0adaee 1
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties, file e177fbc7-9809-50b0-e053-d805fe0adaee 1
Totale 90
Categoria #
all - tutte 253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 1 1 1 3 1 1 2 0 0 0 2 1
2022/202367 2 9 5 3 3 3 15 6 18 3 0 0
2023/20243 0 0 0 0 0 0 1 2 0 0 0 0
Totale 90